America, I’m honored that you have chosen me to lead our great country.
The work ahead of us will be hard, but I promise you this: I will be a President for all Americans — whether you voted for me or not.
I will keep the faith that you have placed in me.
Donald Trump showed the country last night just how unfit he is to be president. If you weren't able to bear watching it, we condensed it down to one minute for you:
There are two systems of justice in America: one for Trump and his cronies—and one for everybody else. It’s not right and people are sick and tired of it. In November, let’s end this national nightmare.
Unprecedented, historic corruption: an American president commutes the sentence of a person convicted by a jury of lying to shield that very president.
This is the most critical election of our lifetimes—and Americans shouldn’t have to miss work, wait for hours, or risk their health to make their voices heard.
Demand your lawmakers take immediate action using our team’s easy tool:
https://t.co/zktcxy8gAG
I’m gonna give away $5,000 to 3 random people who retweets this and follows me! ❤️ Quarantine is lasting way longer than expected and I wanna keep helping out. Love you guys ⭐️
Today on #BPDCNDay, we're bringing awareness to blastic plasmacytoid dendritic cell neoplasm (#BPDCN). Learn more about what #BPDCN is, facts and statistics about the disease, and our resources for patients dealing with this diagnosis. @BPDCNInfo
1/23 is BPDCN Awareness Day! We are committed to helping patients fight and overcome this disease. Help us raise awareness by liking and reposting @BPDCNInfo.
Where there’s hope, there’s a path forward. Kaity shares her thoughts on why raising awareness for #BPDCN can make a meaningful difference in the lives of patients. #BPDCNday
Where there’s hope, there’s a path forward. Kaity shares her thoughts on why raising awareness for #BPDCN can make a meaningful difference in the lives of patients. #BPDCNday
Patients with blastic plasmacytoid dendritic-cell neoplasm (BPDCN), an aggressive hematologic cancer, were treated with the cytotoxin tagraxofusp in a dose-escalation case series. See the results: https://t.co/GnXdSOvblk